This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
BURLINGTON, Mass., Oct. 25, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum at the Westin Grand Central in New York, NY, on Thursday, November 14, 2013. George W. LeMaitre, Chairman & CEO, will provide an update on the Company at 3:00 pm EST.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at
LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.
CONTACT: LeMaitre Vascular, Inc.